Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and 5-FU/LV as third-line treatment for metastatic colorectal cancer
NCT00016198Phase 2Completed
- Sponsor
- Prologue Research
- Start
- May 2001
- Primary completion
- Apr 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin in colorectal cancer (CRC), sponsored by Prologue Research. Started May 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00016198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016198.